HVTN Translational HIV Vaccine Early Stage Investigator (ESI) Conference


The HVTN is proud to announce that it will host the 2021 Translational HIV Vaccine Early Stage Investigator (ESI) Conference. More details to follow soon.

This conference is intended for ESIs who focus on translational HIV research in non-human primates (NHPs), or clinical HIV and TB research. Investigators participating in the conference will gain a sense of their ability to contribute widely to the field and obtain support in reaching career milestones. Past attendees have stated that the Conference has increased their skills and knowledge for career development and provided them with a venue to form new collaborations.


Target Audience:

ESIs who focus on preclinical or clinical HIV vaccine research and are within ten (10) years of completing their terminal research degree, medical residency, or equivalent.


The program for the 2021 Conference is under development.

Contact Information:

For questions, please contact

Danna Flood




Funding for this conference was made possible in part by 2R13OD024033 from the Office of the Director, National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the National Institutes of Health (NIH); nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government